S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
Closing prices for crude oil, gold and other commodities
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Ford, Starbucks fall; Clorox, Gilead Sciences rise
Zimmer Biomet Beats on Earnings, Growth May be Priced In
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
How major US stock indexes fared Friday 2/3/2023
MarketBeat Week in Review – 1/30 - 2/3
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
Closing prices for crude oil, gold and other commodities
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Ford, Starbucks fall; Clorox, Gilead Sciences rise
Zimmer Biomet Beats on Earnings, Growth May be Priced In
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
How major US stock indexes fared Friday 2/3/2023
MarketBeat Week in Review – 1/30 - 2/3
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
Closing prices for crude oil, gold and other commodities
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Ford, Starbucks fall; Clorox, Gilead Sciences rise
Zimmer Biomet Beats on Earnings, Growth May be Priced In
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
How major US stock indexes fared Friday 2/3/2023
MarketBeat Week in Review – 1/30 - 2/3
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
Closing prices for crude oil, gold and other commodities
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Ford, Starbucks fall; Clorox, Gilead Sciences rise
Zimmer Biomet Beats on Earnings, Growth May be Priced In
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
How major US stock indexes fared Friday 2/3/2023
MarketBeat Week in Review – 1/30 - 2/3
NASDAQ:AVRO

AVROBIO - AVRO Stock Forecast, Price & News

$0.93
-0.01 (-1.06%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.90
$0.96
50-Day Range
$0.69
$0.94
52-Week Range
$0.56
$1.90
Volume
362,588 shs
Average Volume
284,247 shs
Market Capitalization
$40.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

AVROBIO MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
330.1% Upside
$4.00 Price Target
Short Interest
Healthy
0.36% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.18) to ($1.60) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.87 out of 5 stars

Medical Sector

604th out of 1,029 stocks

Biological Products, Except Diagnostic Industry

95th out of 169 stocks

AVRO stock logo

About AVROBIO (NASDAQ:AVRO) Stock

Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Cambridge, MA.

Receive AVRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter.

AVRO Stock News Headlines

Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Avrobio, Inc. (NASDAQ: AVRO)
See More Headlines
Receive AVRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter.

AVRO Company Calendar

Last Earnings
11/08/2022
Today
2/04/2023
Next Earnings (Estimated)
3/16/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVRO
Fax
N/A
Employees
122
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.00
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+330.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-119,130,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.88 per share

Miscellaneous

Free Float
40,972,000
Market Cap
$40.71 million
Optionable
Not Optionable
Beta
1.76

Key Executives

  • Geoff MacKay
    President, Chief Executive Officer & Director
  • Erik John Ostrowski
    Chief Financial Officer & Treasurer
  • Kim Raineri
    Chief Manufacturing & Technical Operations Officer
  • Essra Ridha
    Chief Medical Officer
  • Deanna M. Petersen
    Chief Business Officer













AVRO Stock - Frequently Asked Questions

Should I buy or sell AVROBIO stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AVROBIO in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AVRO shares.
View AVRO analyst ratings
or view top-rated stocks.

What is AVROBIO's stock price forecast for 2023?

1 equities research analysts have issued 1 year target prices for AVROBIO's shares. Their AVRO share price forecasts range from $4.00 to $4.00. On average, they anticipate the company's stock price to reach $4.00 in the next year. This suggests a possible upside of 330.1% from the stock's current price.
View analysts price targets for AVRO
or view top-rated stocks among Wall Street analysts.

How have AVRO shares performed in 2023?

AVROBIO's stock was trading at $0.7129 at the start of the year. Since then, AVRO stock has increased by 30.5% and is now trading at $0.93.
View the best growth stocks for 2023 here
.

When is AVROBIO's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 16th 2023.
View our AVRO earnings forecast
.

How were AVROBIO's earnings last quarter?

AVROBIO, Inc. (NASDAQ:AVRO) announced its quarterly earnings data on Tuesday, November, 8th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.50) by $0.02.

What other stocks do shareholders of AVROBIO own?
When did AVROBIO IPO?

(AVRO) raised $75 million in an initial public offering (IPO) on Thursday, June 21st 2018. The company issued 4,400,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Cowen and Wells Fargo Securities acted as the underwriters for the IPO and Wedbush Securities was co-manager.

What is AVROBIO's stock symbol?

AVROBIO trades on the NASDAQ under the ticker symbol "AVRO."

Who are AVROBIO's major shareholders?

AVROBIO's stock is owned by a number of retail and institutional investors. Top institutional investors include GMT Capital Corp (7.56%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Christopher Paige, Geoffrey Mackay and Philip J Vickers.
View institutional ownership trends
.

How do I buy shares of AVROBIO?

Shares of AVRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AVROBIO's stock price today?

One share of AVRO stock can currently be purchased for approximately $0.93.

How much money does AVROBIO make?

AVROBIO (NASDAQ:AVRO) has a market capitalization of $40.71 million. The company earns $-119,130,000.00 in net income (profit) each year or ($2.49) on an earnings per share basis.

How many employees does AVROBIO have?

The company employs 122 workers across the globe.

How can I contact AVROBIO?

AVROBIO's mailing address is ONE KENDALL SQUARE BUILDING 300 SUITE 201, CAMBRIDGE MA, 02139. The official website for the company is www.avrobio.com. The company can be reached via phone at (617) 914-8420 or via email at ir@ampliphibio.com.

This page (NASDAQ:AVRO) was last updated on 2/4/2023 by MarketBeat.com Staff